Glaukos glaucoma net sales $67.2M up 20% year on year.
Their idose TR is really expensive you would think that would lose market share to cheaper options down the track as long as they have similar efficacy
Glaukos glaucoma net sales $67.2M up 20% year on year.Their...
Add EYE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
28.0¢ |
Change
-0.005(1.75%) |
Mkt cap ! $64.07M | |||
| Open | High | Low | Value | Volume |
| 28.5¢ | 28.5¢ | 27.5¢ | $225.7K | 801.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 247909 | 27.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 28.0¢ | 157515 | 2 |
View Market Depth
| Last trade - 15.50pm 22/05/2024 (20 minute delay) ? |
|
|||||
|
Last
28.0¢ |
Change
-0.005 ( 1.82 %) |
||||
| Open | High | Low | Volume | ||
| 28.5¢ | 28.5¢ | 27.5¢ | 321981 | ||
| Last updated 15.54pm 22/05/2024 ? | |||||
| EYE (ASX) Chart |